Clik here to view.
Trends Update — Social Media: Upopolis Keeps SickKids’ Patients Connected
One of the fantastic uses for social media in healthcare (a trend we will be following this coming year) is to connect communities of patients to each other and to their friends and families when those...
View ArticleClik here to view.
Valuation and Other Biotech Mysteries – Part 8: The Current State of...
[Ed. This is the eighth part in Wayne's series. You can access the whole thing by clicking here. Please leave comments or questions on the blog and Wayne will address them in future posts in this...
View ArticleClik here to view.
Valuation and Other Biotech Mysteries – Part 9: Retail Investors
[Ed. This is the ninth part in Wayne's series. You can access the whole thing by clicking here. Please leave comments or questions on the blog and Wayne will address them in future posts in this...
View ArticleClik here to view.
Valuation and Other Biotech Mysteries – Part 10: Some Pharmaceutical Industry...
[Ed. This is the tenth part in Wayne's series. You can access the whole thing by clicking here. Please leave comments or questions on the blog and Wayne will address them in future posts in this...
View ArticleClik here to view.
Valuation and Other Biotech Mysteries – Part 11: Changes in Pharmaceutical...
[Ed. This is the eleventh part in Wayne's series. You can access the whole thing by clicking here. Please leave comments or questions on the blog and Wayne will address them in future posts in this...
View ArticleClik here to view.
Some Top-Line Numbers From 2011 For Public Canadian Healthcare Companies
The numbers have been crunched in preparation for the 2011 Canadian Healthcare Annual Review, which I co-author with Ross Marshall, Senior Vice President at The Equicom Group. Prior to its publication...
View ArticleClik here to view.
Financings by Public Canadian Healthcare Companies in H1 2012
Public Canadian healthcare companies raised over $1 billion in equity and convertible debt financings in the first half of 2012. Before anybody wonders whether another biotech boom has suddenly...
View Article
